SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-028647
Filing Date
2023-08-14
Accepted
2023-08-14 17:14:33
Documents
48
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 698600
2 ex31-1.htm EX-31.1 17587
3 ex31-2.htm EX-31.2 17894
4 ex32-1.htm EX-32.1 7828
5 ex32-2.htm EX-32.2 8098
  Complete submission text file 0001493152-23-028647.txt   3917762

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE murf-20230630.xsd EX-101.SCH 29767
7 XBRL CALCULATION FILE murf-20230630_cal.xml EX-101.CAL 33667
8 XBRL DEFINITION FILE murf-20230630_def.xml EX-101.DEF 176072
9 XBRL LABEL FILE murf-20230630_lab.xml EX-101.LAB 242746
10 XBRL PRESENTATION FILE murf-20230630_pre.xml EX-101.PRE 206752
42 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 536973
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
Murphy Canyon Acquisition Corp. (Filer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41245 | Film No.: 231171968
SIC: 2834 Pharmaceutical Preparations